Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia
BERKELEY, Calif., April 17 /PRNewswire/ -- In recognition of the 20th anniversary of World Hemophilia Day, Bayer HealthCare reaffirmed its commitment to the global hemophilia community by pledging euro
250,000 to the World Federation of Hemophilia (WFH). To mark this milestone, Bayer employees aro...
Michel Nakache Returns to Euro RSCG Life as Worldwide Managing Partner
NEW YORK, May 5 /PRNewswire/ -- Euro
RSCG Life, a leading healthcare
communications network, announced that Michel Nakache has returned to the
agency as Chairman, EMEA and APAC. Nakache will join Doug Burcin and Donna
Murphy as a Worldwide Managing Partner and will be located in the Paris
Charity Raffle Offers Trip and Game Tickets to Soccer's Euro 2008 Quarterfinal
Annandale Rotary Foundation raffle features 30 prizes, benefits global polio eradication and peace-building
ARLINGTON, Va., April 23 /PRNewswire/ -- The Annandale Rotary
Foundation, Inc. has launched a charity raffle offering ticket-holders
attractive odds and a Grand Prize s...
biolitec AG - Record Profit in FY 2006/07 With a Growth of 191% to Euro 6,7 Million
Sales of biolitec AG Increase to More Than Euro
39 Million - Aesthetic Therapies and Ambulant Urology Laser are Growth Drivers - 0.56 Euro
Earnings per Share at June 30, 2007
JENA, Germany, September 28 /PRNewswire-FirstCall/ --
http://www.biolitec.com - biolitec AG, Jena ...
Anti obesity pill gets EURO nod
As an impetus to the weight loss industry a panel comprising European experts recommended Sanofi-Aventis's anti-obesity pill Acomplia be approved for sales// in the European Union. This news was brought to light by the company itself.
The action of the pill Acomplia (rimonabant) is to block a p...
West Announces Second Quarter 2009 Results
... these estimates is
for the translation of the euro
at $1.40 to euro
1.00 for the remainder
of 2009. The Company's earlier guidance reflected the euro
at $1.28 for
the remainder of 2009. The 2009 g...
Uroplasty Reports First Fiscal Quarter Results
...se is mainly attributed to the strengthening of the U.S. dollar against the euro
and the British pound, increased competition from a newly-introduced produc... of a competitive product, the strengthening of the U.S. dollar against the euro
and the British pound, and, as previously noted, distributor issues in a fe...
MedThink Hires Joe Conwell as Executive Creative Director
...evate their products to the forefront of awareness among consumers, patients, physicians and other key audiences."
Conwell joins MedThink from euro
RSCG Life/MetaMax in Princeton, New Jersey, where he served as vice president and associate creative director. Prior to his tenure at Euro, Conwell se...
Wolters Kluwer Health Launches Interactive Platform for Pharmacology Journal Content
...professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of euro
3.4 billion ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America,...
Bolli Becomes New Editor-In-Chief of Circulation Research
...s in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of 3.4 billion euro
($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacifi...
EURO in Medical Technology
First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008
PARIS, March 24 /PRNewswire-FirstCall/ -- The AXA Research Fund closed out its first year of existence. During the year ended, the Fund granted more than Euro
13 million to various European research institutions.
The purpose of the Fund is to promote the understanding and prevention of major ...
Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease
EINDHOVEN, the Netherlands, April 1 /PRNewswire/ -- The Center for
Translational Molecular Medicine (CTMM) - a Dutch public-private
partnership committed to the research and development of new techniques for
the diagnosis and treatment of major diseases - announced today that nine
CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical Research
...olecular Medicine) today announced the successful
completion of 265 million euro
funding for translational (bench-to-bedside)
medical research, making CTMM ... destinations for
translational biomedical research.
"The 15 million euro
allocated to this prostate cancer project, which
brings the total allocated...
CoAxia, Inc. Announces $21.5M Series D Financing
...iences sectors. Since 1972, the firm has financed over 450 companies, many of which have gone public or have been acquired, and currently manages over euro
1 billion in assets. Sofinnova's experienced team and hands-on approach in nurturing and supporting portfolio companies from initial financing to succ...
Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting
(1) N. Pavlidis, E. Briasoulis, J. Hainsworth, F.A. Greco. Diagnostic and therapeutic management of cancer of an unknown primary. euro
J of Cancer. 2003; 39:1990-2005.
(2) D. V. Schapira and A. R. Jarrett. The need to consider survival, outcome, and expense when evaluating and tr...
Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
... fields of central nervous system and immunology disorders. Employing approx. 10 000 people in over 40 countries, UCB achieved revenues of 3.6 billion euro
in 2008. UCB is listed on Euronext Brussels (symbol: UCB).
Forward looking statement
This press release contains forward-looking statemen...
Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis
...d commercialization of drugs for the treatment of ocular diseases, with a special focus on retinal pathologies. Founded in May 2005, Fovea has raised euro
50.5m ($69m) in two financing rounds from a strong international syndicate of investors.
Fovea has built a project portfolio including internal r...
Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
...first clinical trial application (CTA) in Europe by its partner Nycomed for the anti-GM-CSF antibody MT203. Micromet received a payment of 1.5 million euro
(US$ 2.0 million) from Nycomed for the achievement of this milestone.
Under a 2007 agreement between the two companies, Micromet and Nycomed are ...
Drug Development Program Started Based on CAP(R) Human Cell Line
Pharmaceuticals GmbH (Cologne, Germany) and PharmaCell BV (Maastricht, The
Netherlands) announce the start of Theraptech, a 2.4 million euro
protein development program subsidized under the European Trans Bio Program.
The major objective of the Theraptech project is to develop a...
Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
...available in all markets.
With an annual R&D expenditure of around euro
1bn, Merck Serono is committed to growing its business in specialist-focuse...erck is a global pharmaceutical and chemical company with total revenues of euro
7.6 billion in 2008, a history that began in 1668, and a future shaped by 3...
EURO in Biological News
Sweden to host 1.3 billion Euro research center
The world's most powerful neutron source should be built in Lund, Sweden, it has been announced by EU Research Ministers.
At a meeting in Brussels last night (28 May), seven countries voted in support of Lund's bid to host the European Spallation Source (ESS), with a further two voting with the...
EMBO pioneers pension plan for internationally mobile postdoctoral researchers
...f the private pension plan for awardees of the fellowships. The 4.3 million euro
EC funding will allow EMBO to award 35 percent more long-term fellowships a...age researchers. The EMBC support allows for incentive contributions of 100 euro
per month during a two-year fellowship for each EMBO Fellow enrolled in the...
Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market, Finds Frost & Sullivan
...//www.aerospace.frost.com ), Maritime Security Market Assessment-European Union, finds that the market is expected to have total revenues of more than euro
240 million from 2008 to 2015. In this research, Frost & Sullivan's expert analysts examine the following markets: screening and detection systems...
Double success for Instituto Gulbenkian de Ciencia scientists working on chromosome segregation
...some segregation and accurate cell division, has just earned him a paper in Nature Cell Biology and a prestigious EMBO installation grant, of 50,000 euro
per year, for a maximum of five years.
Lars Jansen moved from California to the Instituto Gulbenkian de Cincia (IGC), in Portugal, last year to hea...
'Platforms in space' to help businesses
...ell as having the potential to reduce hospital admissions."
G-STEP will exploit innovation opportunities made available by the flagship 1.4 billion euro
EC/ESA Global Monitoring for Environment and Security (GMES) programme. The GMES programme applies data from satellite, aerial and ground-based earth ...
Accolade for solar-hydrogen project
... and photoreaction engineering, in the Energy Technologies Research Institute (ETRI) and in the Faculty of Engineering, is co-coordinating the 920,000 euro
project which is being carried out in collaboration with Patras University in Greece. Energy from the sun will be collected through a nano-structured ...
SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog
...y, reliability and internationality. In fiscal
2008, Siemens had revenue of euro
77.3 billion and a net income of euro
billion (IFRS). Further information is available on the Internet at:
12 outstanding young scientists named as EMBO Young Investigators
... neurobiology field - provide a platform to start new collaborations or exchange PhD students between labs.
EMBO Young Investigators receive 15,000 euro
per year directly from the member state where their laboratories are located. Additional support is provided by EMBO for networking activities and sma...
Cleaning heavily polluted water at a fraction of the cost
...works great," says Professor Racys. "We couldn't believe the results the first time. It has a high capacity, processing 160 m3 per hour. The cost is 1 euro
for every 3.5 litres. Effectively it's 10 or 20 times better than what else is available."
But that's not the end of it. The purity of the end wate...
Entrust Expands Relationship with Slovenia, Implements Second-generation ePassport Solution
... gross national product of approximately $48 billion. As the first
of the 10 new members to join the European Union in 2004, Slovenia also
adopted the euro
as its official currency in January 2007, making it the
13th country to join the European monetary union. Slovenia was also the
first among new EU mem...
EURO in Biological Technology
Index Ventures Closes Euro 350 Million Early Stage Fund
Ben Holmes Named Partner
LONDON, March 3 /PRNewswire/ -- Index Ventures today announced the closing of a euro
350 million early stage fund, Index Ventures V. The fund is dedicated to early stage and seed investments in the technology, biotechnology and clean technology sectors across Europ...
AFFiRiS - MIG-Fonds Increases Investment by Euro 3 Million
VIENNA, Austria, September 25 /PRNewswire/ -- The successful progress
of several vaccine programmes run by AFFiRiS GmbH has prompted investor MIG
AG to increase its investment in the company. It has set up two new funds -
MIG 5 and MIG 7 - to give private investors in Germany and Austria the
TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
NEW YORK, MUNICH, Germany and AMSTERDAM, Netherlands, Aug. 21
/PRNewswire/ -- Paul Capital Healthcare and SpePharm Holding, B.V., the
pan-European specialty pharmaceutical company, today announced that they
have entered into a euro
10 million revenue interest acquisition financing
Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement
NEW YORK and WINNERSH, England, April 21 /PRNewswire/ -- Paul Capital
Healthcare and Vernalis plc (LSE: VER) today announced that they have
signed a financing agreement relating to frovatriptan, Vernalis' product
for the treatment of migraine. Under the agreement, Vernalis will receive
Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
EATONTOWN, N.J., April 18 /PRNewswire-FirstCall/ -- Osteotech, Inc.
(Nasdaq: OSTE ), a leader in the emerging field of biologic solutions for
regenerative medicine, announced today that it has renewed its exclusive
tissue recovery agreement with The Euro
Atlantic Transplant Alliance
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
...n the following exchange rate scenarios, which are not
forecasts, the impact on our base guidance would be:
fx GBP fx Non GAAP diluted
rate rate earnings per ADS
Sanofi-aventis Announces Second Quarter 2009 Results
...---- ------- ------- -------
sales 7,... net
American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals
...8 (Sept. 30), Siemens Healthcare reported sales of euro
11.2 billion, orders of euro
11.8 billion, and Sector profit of euro
1.2 billion. Further information can be found by v...
Essilor : First Half 2009 Revenue
...ve currency effect was mainly due to the US dollar's 15.4%
gain against the euro
during the period. On the downside, reported revenue
was reduced by the declines against the euro
in the British pound (down
12.4%), the Brazilian real (down 10.9%) and the ...
Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain
... Global Market. A non-profit Foundation, jointly sponsored by ROVI and the Spanish authorities, will be formed and initially funded with a 25 million euro
credit line from the Spanish government, to support Phase III clinical development and other studies necessary to achieve marketing authorization of t...